Company Filing History:
Years Active: 2013-2016
Title: Innovations by James S. Jensen: A Pioneer in Sustained-Release Pharmaceutical Compositions
Introduction: James S. Jensen, a distinguished inventor based in Edina, MN, is renowned for his contributions to the field of pharmaceuticals. With a portfolio of four patents, Jensen has made significant strides in developing sustained-release formulations that integrate non-opioid amines with non-steroidal anti-inflammatory drugs.
Latest Patents: Among his latest innovations, James S. Jensen has developed a sustained-release product that combines a non-opioid amine with a non-steroidal anti-inflammatory drug. This sustainable release oral pharmaceutical composition offers a unique approach, featuring an amine-containing compound along with a hydrophilic matrix. The composition is designed to be delivered in a single dosage form, providing both efficacy and convenience for patients.
Career Highlights: James S. Jensen's career is marked by his impactful work at Upsher Smith Laboratories, Inc. His expertise in pharmaceutical sciences has allowed him to focus on creating innovative solutions that enhance patient care through improved drug delivery systems. His commitment to innovation has solidified his standing in the industry as a forward-thinking inventor.
Collaborations: During his professional journey, James has collaborated with notable colleagues, including Christian F. Wertz and Victoria Ann O'Neill. These collaborations have fostered an environment of innovation and creativity, driving advancements in pharmaceutical technologies.
Conclusion: James S. Jensen continues to be a significant figure in the pharmaceutical industry. His work in developing sustained-release products illustrates his dedication to improving patient outcomes and exemplifies the spirit of innovation that drives progress in modern medicine. His contributions will undoubtedly have a lasting impact on the field.